Cadetii IQads petrec si invata in Club Control Bucuresti, 23 februarie 2010 – Club Control, cel mai mare club de muzica indie/alternative din Bucuresti a devenit clubul oficial in care cadetii IQads vor avea ocazia sa invete despre industria de marketing si comunicare si in acelasi timp sa petreaca alaturi de colegii din proiect. IQads |
Health News |
||||||
| ||||||
|
Male Batterers Consistently Overestimate General Rates Of Violence Toward Partners Men who engaged in domestic violence consistently overestimated how common such behavior is, and the more they overestimated it the more they engaged in abusing their partner in the previous 90 days, according to new research conducted at the University of Washington... Superbug MRSA on rise in Canada There has been a dramatic increase in the number of cases of Canadians becoming infected or colonized by the superbug MRSA since 1995, both in hospitals and within the community, a study has found. Development Of New Scale To Measure Anxiety Outcomes A new questionnaire and outcomes measurement scale developed by the department of psychiatry at Rhode Island Hospital has proven to be a reliable and valid measure of anxiety. The scale can easily be incorporated into routine clinical practice when treating psychiatric disorders. The study appears online ahead of print in the Journal of Clinical Psychiatry... Hepatitis C And Insulin Resistance - Surprising Findings We have known for several years that Hepatitis C, a common cause of liver cirrhosis and cancer, also makes people three to four times more likely to develop Type 2 diabetes. In studying the insulin resistance of 29 people with Hepatitis C, Australian researchers have confirmed that they have high insulin resistance, a precursor to diabetes... U.N. Official Addresses Increasing Drug Addiction In Developing Countries The U.N. Office on Drugs and Crime (UNODC) on Monday warned of an impending "health disaster facing developing countries if wealthy nations fail to control drugs," Agence France-Presse reports... Cellectar Completes Enrollment In Phase I Clinical Trial Of Lead Drug Candidate (131)I-CLR1404 For The Treatment Of Solid Malignancies Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year... Scivanta Medical Corporation Announces Results For Initial Clinical Trial For The Scivanta Cardiac Monitoring System Scivanta Medical Corporation (OTC Bulletin Board: SCVM), announced that the results of its initial clinical trial for the Scivanta Cardiac Monitoring System (SCMS) clearly indicate that the SCMS can accurately measure cardiac performance as expected by the company. This clinical trial was performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, New York... Designer Nano Luggage To Carry Drugs To Diseased Cells For the first time, scientists have succeeded in growing empty particles derived from a plant virus and have made them carry useful chemicals. The external surface of these nano containers could be decorated with molecules that guide them to where they are needed in the body, before the chemical load is discharged to exert its effect on diseased cells... Professor Discovers Link Between Low Oxygen Levels In Body And Cancer-Aiding Protein; Could Help Treatments For Retinoblastoma, Breast Cancer What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma... Graceway Announces Journal Of The American Academy Of Dermatology Publishes Articles On New Short-Course Imiquimod Formulation In Actinic Keratosis The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on either 2-week or 3-week treatment cycles. While all study arms met the primary endpoint of complete clearance versus placebo, data suggest that, of the regimens studied, imiquimod 3... Critical Recommendations Unveiled To Respond To National Public Health Crisis: Deep-Vein Thrombosis And Pulmonary Embolism Three critical recommendations from a national workshop have been released to address deep-vein thrombosis (DVT) and pulmonary embolism (PE), a growing public health problem estimated to affect nearly 1 million Americans each year... Rexahn Pharmaceuticals Issued Japanese Patent For Anti-cancer Compound Archexin(R) Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin®... B.C. to market health tourism B.C. Health Minister Kevin Falcon says he has a plan to market health-care services to rich, offshore patients similar to the way the province sells higher education to foreign students. ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA And EU COMP ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC)... Avastin fight now moves to P.E.I. A cancer patient who successfully helped lobby the New Brunswick government to fund an expensive cancer drug is now shifting his focus to P.E.I. in an effort to have Avastin funded by that province. |
||||||
| 1 2 3 4 [>] [>>] |
| Categories |
| ◊ Politics News |
| ◊ Business News |
| ◊ Economics News |
| ◊ Sports News |
| ◊ Entertainment News |
| ◊ Tech & science News |
| ◊ Others News |
| ◊ Health News |
| ◊ Money News |
| ◊ Arts News |
| ◊ Travel News |